Send me a link:

*Text messaging rates may apply.

 Dow Down0.72% Nasdaq Down0.50%

More On ANPMF

Quotes

Charts

News & Info

Company

  • Profile
  • Key Statistics
  • SEC Filings
  • Competitors
  • Industry
  • Components

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


Angiotech Pharmaceuticals Inc. (ANPMF)

-Other OTC
25.00 0.00(0.00%) Mar 28, 11:58AM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2012Sep 30, 2012Jun 30, 2012Mar 31, 2012
Total Revenue 65,299   56,637   61,339   60,550  
Cost of Revenue26,975  24,169  27,386  24,794  
Gross Profit 38,324   32,468   33,953   35,756  
Operating Expenses
Research Development1,249  1,399  2,423  1,985  
Selling General and Administrative19,545  16,009  17,785  17,646  
Non Recurring289   -  692  173  
Others8,607  8,445  8,428  9,023  
Total Operating Expenses29,690   -  29,328  28,827  
Operating Income or Loss 8,634   6,615   4,625   6,929  
Income from Continuing Operations
Total Other Income/Expenses Net153  (5,079)387  110  
Earnings Before Interest And Taxes8,787  1,536  5,012  7,039  
Interest Expense6,284  5,548  4,306  4,252  
Income Before Tax2,503  (4,012)706  2,787  
Income Tax Expense(2,826)4,596  3,654  2,786  
Minority Interest -   -   -   -  
Net Income From Continuing Ops5,329  (8,608)(2,948)1  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 5,329   (8,608) (2,948) 1  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 5,329   (8,608) (2,948) 1  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.